Dr Adam Brentnall: key facts
- Kind of voice
- Academic
- Role
- Reader in Biostatistics at Queen Mary's Wolfson Institute of Population Health
- Quoted on
- Cancer
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
“These findings suggest the need for more targeted, age-informed PSA testing or prostate cancer screening policies, including reexamining PSA testing policies in settings where they have led to high rates of opportunistic screening in older men, like the UK.”
What Dr Adam Brentnall has said
“Long-term data from high-quality randomised trials provides key evidence to determine suitability of screening. However, it's not sufficient on its own to decide whether an organised national screening programme should be introduced. We also need to weigh broader benefits, harms, and costs.”
reader in biostatistics, Queen Mary, University of London · Cancer · 10 Sept 2026 · Cochrane reviewers conclude PSA testing reduces deaths from prostate cancer ↗
Where Dr Adam Brentnall has been quoted
- FMD - Prostate cancer overdiagnosis rises sharply with ageqmul.ac.uk · 30 Sept 2026
- Cochrane reviewers conclude PSA testing reduces deaths from prostate cancerpulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.